Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097773 · ClinicalTrials.gov registry record · Phase 2
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
A Phase 2 study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 304
- Enrollment target
NCT00097773 is a Phase 2 study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 304 participants.
The verdict
NCT00097773, a Phase 2 study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 304 participants
- Enrollment target
Study Summary
Cystic fibrosis (CF) is a chronic disease that significantly affects an individual's lung function. Antibiotic medications have been proven effective at reducing Pseudomonas aeruginosa (PA) infection, which is one of the main causes of death in individuals with CF. The purpose of this study is to compare the effectiveness of treatment based on quarterly culture results versus consistent quarterly antibiotic treatment at reducing PA infection in children with CF.
Interventions
- DRUG Oral placebo
- DRUG Tobramycin solution for inhalation (TOBI)
- DRUG Oral ciprofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00097773
The ClinicalTrials.gov registry entry for NCT00097773 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Oral placebo is the first listed.
NCT00097773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00097773 about?
NCT00097773 is a clinical study titled "Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis". Cystic fibrosis (CF) is a chronic disease that significantly affects an individual's lung function. Antibiotic medications have been proven effective at reducing Pseudomonas aeruginosa (PA) infection, which is one of the main causes of death in individuals with CF. The purpose of this study is to co...
What is the current status of trial NCT00097773?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 304 participants. The study started on 2004-09. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00097773?
The interventions under investigation include: Oral placebo (DRUG), Tobramycin solution for inhalation (TOBI) (DRUG), Oral ciprofloxacin (DRUG).
Who is sponsoring clinical trial NCT00097773?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.